Novarica pioneers breakthrough medical technologies that transform patient outcomes through precision biologics, regenerative medicine, and cutting-edge cell therapy solutions.
Empowering healthcare providers, researchers, and life science organizations with innovative medical technologies, strategic partnerships, and scientific expertise.
Patient-derived biological therapies using autologous cells for personalized treatment protocols with minimal rejection risk.
Explore →Advanced cellular treatments leveraging stem cells, CAR-T, and regenerative technologies for complex conditions.
Explore →State-of-the-art medical equipment engineered for precision diagnostics and therapeutic interventions.
Explore →Strategic collaborations with world-leading research institutions and healthcare organizations worldwide.
Explore →We combine decades of biomedical research with clinical expertise to develop therapies that truly make a difference in patients' lives.
Rigorous protocols backed by peer-reviewed research and international standards.
Every product and therapy undergoes extensive safety validation before clinical application.
Our R&D team constantly explores next-generation techniques in regenerative medicine.
Driven by science. Committed to healing.
NOVARICA is a healthcare and biomedical company focused on developing and delivering advanced Auto Biologics and Cell Therapy solutions.
Founded to bridge cutting-edge research with real-world clinical applications, led by a dynamic team of biomedical scientists.
We ensure every therapy and product meets the highest standards of quality, safety, and efficacy. We operate at the intersection of science and compassion.
Patient-derived solutions crafted with precision.
Advanced therapies guided by scientific rigor.
Quality, safety, and efficacy in every outcome.
To develop scientifically validated autologous biologics and cell therapy solutions that are safe, effective, and affordable, empowering healthcare providers to achieve superior patient outcomes through scientific innovation, clinical excellence.
To be a globally recognized company in autobiologics and cell therapy, pioneering solutions that transform and redefine the future of medicine and improve patients' quality of life.
Continuously pushing the boundaries of what's possible in healthcare science.
Transparency and ethical conduct in every research, clinical, and business decision.
Uncompromising standards across product development, manufacturing, and delivery.
Keeping the patient at the heart of everything we develop and deliver.
Rigorous validation and monitoring at every stage of therapy development.
Personalized therapy from your own biology
Autologous biologics prepared from a patient's own blood, plasma, platelets, growth factors and cells. These therapies use the patient's own tissues, they minimize the risk of immune rejection and disease transmission while supporting the body's natural healing and regenerative processes.
At NOVARICA, we leverage advanced separation, concentration, and processing technologies to develop high-quality autologous biologic therapies with precision, consistency, and safety. Our solutions are designed to maximize therapeutic potential, enhance clinical outcomes, and enable personalized regenerative care across a wide range of medical applications.
Blood, plasma, platelets, growth factors and cells from the same patient.
Minimizes immune rejection and disease transmission risk.
Advanced separation and concentration for consistent, safe therapies.
Autologous materials eliminate HLA mismatch and immune rejection completely.
Growth factors and bioactive proteins accelerate tissue repair and regeneration.
Therapy concentration adjusted based on individual patient biology and condition.
Point-of-care preparation reduces contamination risk and processing time significantly.
Harnesses the body's own regenerative mechanisms for sustainable recovery.
Eliminates need for donor sourcing, matching, and associated logistics costs.
PRP and BMC therapy for joint repair, tendon healing, and cartilage regeneration.
Accelerated recovery from sports injuries using autologous growth factor therapies.
Neuroprotective biologics for degenerative conditions and neural tissue repair.
Autologous cardiac cell therapies for myocardial repair post-infarction.
PRP-based skin rejuvenation, wound healing, and hair restoration treatments.
Autologous fibrin matrices for oral surgery, implant integration, and wound healing.
Minimal blood or tissue collection from the patient in a sterile clinical setting.
Advanced centrifugation and separation to concentrate biological components.
Bioactivation protocols to enhance therapeutic potency of the preparation.
Precise delivery to target tissue using image-guided or direct injection techniques.
Regenerating life at the cellular level
Cell therapy is transforming the landscape of modern medicine by harnessing the power of living cells to repair, regenerate, and restore damaged tissues. Unlike conventional treatments that primarily manage symptoms, cell-based therapies target the underlying biological mechanisms of disease, offering the potential for long-lasting and personalized clinical outcomes.
At NOVARICA, we are advancing the future of regenerative healthcare through innovative cell therapy solutions. Our expertise spans stem cell therapies, CAR-T cell technologies, mesenchymal stromal cell (MSC) applications, and advanced immune cell engineering. Developed using rigorous scientific standards and GMP-compliant manufacturing processes, designed to deliver safe, effective, and patient-centric solutions for the next generation of medicine.
Repair and regenerate damaged tissues with living cells.
Targeted cell technologies for precise clinical impact.
Safe, effective, patient-centric solutions for next-gen medicine.
Chimeric Antigen Receptor T-cell therapy engineered to precisely target and destroy cancer cells with unprecedented specificity.
Hematopoietic and mesenchymal stem cell therapies for tissue regeneration, immune modulation, and degenerative disease treatment.
Induced pluripotent stem cell technology enabling patient-specific cell lines for personalized therapies and disease modeling.
Natural Killer cell therapies harnessing innate immune power for cancer immunotherapy without complex genetic engineering.
Engineering armored CARs with enhanced persistence and reduced exhaustion.
MSC-mediated drug delivery vehicles for solid tumor therapy.
First-in-human iPSC-derived NK cell therapy for hematologic cancers.
Expanded trials for orthopedic and neurological conditions.
Engineering precision tools for advanced therapy
Supports functionally closed manufacturing and helps reduce contamination risk in sterile tubing connections.
Simplified cell expansion on one automated platform — scalable from process development to commercial manufacturing.
A purpose-built, automated system for cell therapy fill and finish — consistent, high-quality results for suspension and adherent cells.
Visionaries driving healthcare transformation
Managing Director & Chief Scientific Officer
Nagarjuna Daram, Manging Director is a biomedical scientist with 10 years of research and clinical experience in cell therapy and regenerative medicine. He has earned Ph.D. in Biomedical sciences from University of Delhi and also been post-doctoral fellow in renowned IIT Delhi and IIT Roorkee.
He worked extensively with clinicians and led to the development of multiple projects from concept to clinical deployment.
"Science without compassion is incomplete. At Novarica, we never forget that behind every data point is a patient whose life we have the privilege to impact."
"We are at a pivotal moment in medical history where the convergence of cell biology, genetic engineering, and artificial intelligence opens entirely new frontiers in healing. Novarica's leadership is committed to steering this potential toward real, equitable patient benefit across India and around the world."
— Dr. Nagarjuna Daram, MD & CSO
Building the future of medicine together
Novarica's strength lies in its collaborative ecosystem spanning research, manufacturing, clinical, and distribution partnerships worldwide.
Collaborations with leading universities and research institutions driving basic science and translational research.
GMP manufacturing alliances ensuring world-class production standards for all therapeutic products.
International technology collaborations bringing cutting-edge platforms to our product development pipeline.
Hospital and clinic networks deploying Novarica therapies and providing real-world clinical evidence.
We welcome research institutions, hospitals, biotech companies, and distributors to explore collaboration opportunities that advance healthcare together.
We'd love to hear from you
1st Floor, Plot 68, Office 3,
Water Tank Road,
9th Phase, KPHB,
Hyderabad - 500072,
Telangana, India
Novaricameditech@gmail.com
arjun@novaricmeditech.com
+91 40 2345 6789
+91 8882270990 (WhatsApp)
Monday - Friday: 9:00 AM - 6:00 PM
Saturday: 9:00 AM - 1:00 PM
Sunday: Closed
Tagline